TY - JOUR
KW - Adult
KW - Amphetamine-Related Disorders/drug therapy/therapy
KW - cognitive behavioral therapy
KW - Combined Modality Therapy
KW - Double-Blind Method
KW - Female
KW - Humans
KW - Male
KW - Methamphetamine/adverse effects
KW - Nicotinic Agonists/therapeutic use
KW - Treatment Outcome
KW - Varenicline/therapeutic use
KW - methamphetamine dependence
KW - Relapse
KW - Varenicline
AU - M. Briones
AU - S. Shoptaw
AU - R. Cook
AU - M. Worley
AU - A. N. Swanson
AU - D. E. Moody
AU - W. B. Fang
AU - J. Tsuang
AU - B. Furst
AU - K. Heinzerling
A1 - 
AD - Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: Mbriones@mednet.ucla.edu.; Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, USA.; Center for Human Toxicology, Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, USA.; Center for Human Toxicology, Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, USA.; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.; Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
BT - Drug and alcohol dependence
C5 - Opioids & Substance Use
DO - 10.1016/j.drugalcdep.2018.04.023
JF - Drug and alcohol dependence
LA - eng
M1 - Journal Article
PB - Elsevier B.V
PY - 2018
SN - 1879-0046; 0376-8716; 0376-8716
SP - 30
EP - 36
EP - 
T1 - Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trial
T2 - Drug and alcohol dependence
TI - Varenicline treatment for methamphetamine dependence: A randomized, double-blind phase II clinical trial
U1 - Opioids & Substance Use
U2 - 29860057
U3 - 10.1016/j.drugalcdep.2018.04.023
VL - 189
VO - 1879-0046; 0376-8716; 0376-8716
Y1 - 2018
Y2 - Aug 1
ER -